The Filing Desk

HUTCHMED (China) vs OPKO Health

HUTCHMED (China) HCM · OPKO Health OPK · Pharmaceuticals

OPKO Health reported revenue of $607 million in fiscal 2025, about the same as HUTCHMED (China)'s $548 million in fiscal 2025. HUTCHMED (China)'s revenue fell 13.0% in its latest year, and OPKO Health's fell 14.9%. HUTCHMED (China) had an operating margin of -7.1%, against -19.4% at OPKO Health. Free cash flow was −$79 million at HUTCHMED (China) and −$191 million at OPKO Health.

Side by side

HUTCHMED (China)OPKO Health
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$548M$607M
Revenue growth−13.0%−14.9%
Revenue growth a year, last 5 years19.2%−15.8%
Gross margin38.7%33.9%
Operating margin−7.1%−19.4%
Net margin83.3%−37.2%
Free cash flow−$79M−$191M
Free cash flow margin−14.4%−31.4%
Return on capital—−7.0%
Net debt to EBITDA——
Dividends and buybacks$0M$47M
Change in diluted share count0.0%8.2%
Last close$13.45$1.61
P/E at the last close——
Insider trades, last 12 months—bought $1.6 million, sold $0
Piotroski F-score4 of 94 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
HUTCHMED (China)OPKO Health
Operating margin
Percent of revenue
HUTCHMED (China)OPKO Health
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
HUTCHMED (China)OPKO Health

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the HUTCHMED (China) and OPKO Health pages.